Northside Capital Management, LLC Bristol Myers Squibb CO Transaction History

Northside Capital Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 28, 2021	SELL	$61.91 - $67.42 $9,905 - $10,787	-160 Reduced 3.52%	4,380 $293,000
Q1 2021 Apr 27, 2021	BUY	$59.34 - $66.74 $5,399 - $6,073	91 Added 2.05%	4,540 $287,000
Q3 2020 Oct 13, 2020	SELL	$57.43 - $63.64 $111,701 - $123,779	-1,945 Reduced 30.42%	4,449 $268,000
Q2 2020 Jul 15, 2020	BUY	$54.82 - $64.09 $350,519 - $409,791	6,394 New	6,394 $376,000
Q3 2018 Oct 11, 2018	SELL	$55.19 - $62.25 $287,539 - $324,322	-5,210 Closed	0 $0
Q2 2018 Jul 11, 2018	BUY	$50.53 - $62.98 $263,261 - $328,125	5,210 New	5,210 $288,000

2,536

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $120B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Northside Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Northside Capital Management, LLC with notifications on news.